NCT00126009View on ClinicalTrials.gov

SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

May 31, 2004

Conditions

Bipolar Disorder

Interventions

DRUG

Amisulpride

Trial Locations (5)

Unknown

Sanofi-Aventis, Prague

Sanofi-Aventis, Paris

Sanofi-Aventis, Warsaw

Sanofi-Aventis, Bratislava

Sanofi-Aventis, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY